Welcome to our dedicated page for CENTAMIN PLC ORD news (Ticker: $CELTF), a resource for investors and traders seeking the latest updates and insights on CENTAMIN PLC ORD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CENTAMIN PLC ORD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CENTAMIN PLC ORD's position in the market.
Centamin PLC announced that 31.29% of the 2021 share awards under the Company's Remuneration Policy and Performance Share Plan have vested. The awards are for ordinary shares of nil par value and carry the right to dividend equivalents. Directors will hold vested shares for two years. Disposals are to cover tax liabilities. The company's long term incentive plans and performance conditions can be found in the 2023 Annual Report and Accounts.
Centamin PLC announced its total voting rights, with a total issued share capital of 1,161,082,695 ordinary shares, each carrying one voting right. Shareholders can use this information to determine their interest in the company under FCA rules.